Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaÉric Jourdan, Hervé Dombret, Odile Blanchet et al.|Blood|2013Cited by 357
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donorsÉolia Brissot, Mohamad Mohty, Myriam Labopin et al.|Journal of Hematology & Oncology|2020Cited by 68
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)Luca Lanino, Vladan Vučinić, Anthony M. Hunter et al.|Blood|2024Cited by 3